Daily Stock List
Sionix Corp. (SINX)
PennyTrader Publisher reported earlier on Sionix Corp. (SINX), and we highlight the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTCQB, Sionix Corp. is a designer of innovative and patented advanced Mobile Water Treatment Systems (MWTS). The design of these is for use in energy projects. These include subterranean fracturing used in oil and gas drilling, government facilities, healthcare facilities, emergency water supplies, housing development projects, and various other industrial processes. Sionix is based in Los Angeles, California.
The Company's MWTS can be located next to contaminated water sites or as a pre-treatment for reverse osmosis and other membrane applications. Industries involved in dairy, agribusiness, meat processing, mining, poultry operations, and several others can benefit from the Company's cost-effective, maintenance-friendly, portable water treatment systems.
Concerning Sionix' Technology, using a patented Dissolved Air Flotation (DAF) technology packaged in a mobile shipping container, air bubbles between the size of 1 and 2 microns are injected and float organic contaminants to the surface where 99.95 percent are skimmed off, and a majority of inorganic contaminants are captured and removed. This is compared to standard DAF units that normally have been limited to using bubble sizes of 50 microns or larger. The size of these bubbles is significant: the smaller the bubble, the greater the surface tension. They can then hold together longer and elevate contaminants that are more organic to the surface for removal.
Earlier this month, Sionix provided an update on their Madava Farms - Crown Maple Project in New York. Sionix personnel recently completed the integration of Sionix technology with the key systems of the Madava Farms syruping process and successful onsite testing of the Maple Sap Filtration Unit (MSFU). The proposed modifications were agreed upon, principally as they relate to filtration and aeration components in the evaporative process. Sionix personnel will be responsible for the integration of the components of the MSFU components, and its subsequent operation, maintenance, and performance in New York.
Sionix Corp. (SINX), closed Wednesday's trading session at $0.025, down 3.85%, on 349,552 volume with 9 trades. The average volume for the last 60 days is 763,287 and the stock's 52-week low/high is $0.0111/$0.144.
Atlatsa Resources Corp. (ATL)
Uncommon Wisdom reported last week on Atlatsa Resources Corp. (ATL), Street Insider, SmarTrend Newsletters, TradingMarkets, Barchart, StreetAuthority Daily, DrStockPick did earlier, and we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Atlatsa Resources Corp. is a platinum group metals (PGM) mining, exploration, and development company. They control the third largest PGM resource base in South Africa. The Company formerly went by the name Anooraq Resources Corp. They changed their name to Atlatsa Resources Corp. in May 2012. Atlatsa Resources is based in Sandton, South Africa.
The Company controls and operates the Bokoni Platinum Mines, located on the eastern limb of the Bushveld Complex, and maintains a controlling interest in the Ga-Phasha Project, located adjacent to Bokoni, and the Boikgantsho and Kwanda Projects. The Bushveld Complex hosts several PGM mines and prospects. These are mainly within the Merensky and UG2 reefs and the Platreef mineralized horizons.
Atlatsa Resources completed the acquisition of a controlling interest in Bokoni Platinum Mines from Anglo Platinum in July of 2009. They now operate this four-shaft mine complex, presently producing approximately 150000 4E ounces on an annualized basis. The Bokoni property consists of seven mining licences covering an area of approximately 15,000 hectares.
Due to the completion of the Bokoni Transaction on July 1, 2009, Atlatsa effectively owns 51 percent of the Ga-Phasha Project. The property has measured and indicated mineral resources of approximately 25.7Moz 4E and inferred mineral resources of 64.7Moz 4E. Studies are currently underway to assess potential synergies between Bokoni and Ga-Phasha.
Atlatsa Resources' Boikgantsho asset is on the northern limb of the Bushveld Complex, and next to Anglo Platinum's Mogalakwena Mine. This project was acquired via a land acquisition by Atlatsa in 2000 and a joint venture with Anglo Platinum in 2004. Initial drilling has produced indicated mineral resources of 7.7Moz (3E), 230,000t of nickel and inferred resources of 4.1Moz 3E, 75,000t of nickel. A pre-feasibility study is underway; initial assessments point to an open-pit operation with a 32-year life-of-mine at 400,000tpm with a low strip ratio of 1,7:1.
With the completion of the Bokoni Transaction, Atlatsa effectively owns 51 percent of the Kwanda Project. During the third quarter ended September 30, 2012, the Company completed the first phase (Phase One) of the restructure plan for the refinancing, recapitalization and restructure of the Company and the Bokoni Group, with Anglo American Platinum Ltd. This resulted in the Company consolidating all of their debt and lowering their cost of borrowing going forward.
On October 1, 2012, an unprotected strike began at Bokoni, a consequence of the strike contagion within the sector. Because of the strike action, approximately 2,500 employees at the mine have now been dismissed. No operations, other than essential services, have taken place at Bokoni since the start of the strike. The financial and operational implications of the strike will have a negative impact on Atlatsa Resources operational and financial performance going forward and will need to be contemplated between Anglo Platinum and the Company in their final analysis of Phase Two of the Company's Restructure Plan.
Atlatsa Resources Corp. (ATL), closed Wednesday at $0.15, down 5.66%, on 46,209 volume with 33 trades. The average volume for the last 60 days is 129,695 and the stock's 52-week low/high is $0.1101/$0.63.
E-Waste Systems, Inc. (EWSI)
PhD-Trading, TooNiceStocks, ChartPoppers, Greenbackers, 1-2-3 Stock Alerts, The Stock Scout, and Penny Stock Pros reported earlier on E-Waste Systems, Inc. (EWSI), and we are reporting on the Company, here at the QualityStocks Daily Newsletter.
E-Waste Systems, Inc. formed to create a market-leading, integrated business in the emerging waste electrical and electronics equipment (WEEE) industry. They target businesses facing regulatory or other mandates for handling e-waste. The Company's plan is to acquire a select number of high-quality companies with strong management teams that have a shared commitment to helping customers achieve cost effective and environmentally responsible compliance with e-waste recycling and disposal requirements. E-Waste Systems has their headquarters in London, England.
The Company will take advantage of and extend their acquisitions' established customer relationships through expanding the services offered to customers, applying best practices in professional management, and by investing in state-of-the-art recycling technology. They base their categories of e-waste on the WEEE Directive categories; they operate a zero-landfill objective. E-Waste Systems has advanced state-of-the-art processes to achieve maximum extraction of materials to produce new manufacturing input.
For E-Waste Recycling, E-Waste Systems offers multi-national WEEE-Directive standards of recycling and secure asset recovery and end of life management services. These include management of a client's returns, refurbishment of still useful items, re-use/resale, and complete recycling services. They recycle entire ranges of electronic waste including small domestic appliances to computer equipment, televisions to medical equipment, and electronic toys to electronic tools. They operate with a zero-landfill objective and provide certificates of data destruction with access to visual evidence of the processing.
The Company started a new division of E-Waste Systems as a key step in the execution of the fair-trade e-waste program. Under this program, end-of life electronics sourced in either the U.S. or Mexico can undergo processing via a highly compliant partner network of facilities with access to up to 500,000 square feet of space located primarily in Texas, California and northern Mexico.
E-Waste Systems has acquired Tech Disposal, Inc. Tech Disposal is an electronic waste recycler and asset recovery specialist based in Columbus, Ohio. In addition, in September 2012, the Company announced that they entered into preliminary teaming agreements with industry firms in Texas, Ohio and Southern California to develop, expand and support each company's respective e-waste client base and jointly pursue additional customer engagements. These potential additions complement E-Waste Systems' previously announced formal teaming agreements with Zak Enterprises, San Francisco California; and CR Electronics, New Hampshire.
E-Waste Systems, Inc. (EWSI), closed Wednesday's trading session at $0.0066, down 33.33%, on 50,676 volume with 4 trades. The average volume for the last 60 days is 224,257 and the stock's 52-week low/high is $0.0035/$0.047.
Nautilus Minerals, Inc. (NUSMF)
Today we are reporting on Nautilus Minerals, Inc.(NUSMF), here at the QualityStocks Daily Newsletter.
Headquartered in Brisbane, Australia, Nautilus Minerals, Inc. is an exploration stage company that engages in the exploration and development of the ocean floor for copper, gold, silver, and zinc Seafloor Massive Sulphide (SMS) deposits in Australasia. Nautilus is the first company to explore the ocean floor for polymetallic Seafloor Massive Sulphide deposits. The Company lists on the OTCQX International.
Nautilus Minerals' major shareholders include Metalloinvest, the largest iron ore producer in Europe and the CIS, which has a 21 percent holding, international mining group Anglo American, which holds an 11.1 percent interest and MB Holdings, an Oman based group with interests in mining, oil and gas, which holds a 16.9 percent interest.
Nautilus Minerals is developing their first project at Solwara 1, in the territorial waters of Papua New Guinea (PNG). The Solwara 1 Project is located at 1600 meters water depth in the Bismarck Sea, PNG. At Solwara, the Company's goal is to produce copper, gold and silver. Nautilus has been granted all necessary environmental and mining permits.
In addition, the Company holds approximately 500,000 km2 of highly prospective exploration acreage in the western Pacific; in PNG, the Solomon Islands, Fiji, Vanuatu and Tonga, and in international waters in the eastern Pacific.
Last week, Nautilus Minerals announced the release of their unaudited consolidated financial results for the third quarter ended September 30, 2012 together with Management's Discussion and Analysis. Significant events include $90.9 million (equivalent) in cash and cash equivalents as at September 30, 2012; the issuance of Options and Loan Shares; the issue of 37.7 million shares in a private placement to raise approximately C$34 million; and an NI 43-101 Resource Report for Polymetallic Nodules in the Eastern Pacific was released.
Significant events also include Mr. Mike Johnston, Nautilus' Vice President for Strategic Development and Exploration accepting the position of interim President and CEO; the discovery of two high-grade systems in Tonga, and the termination of the equipment build for the Solwara 1 Project.
Concerning the equipment build, Nautilus announced that they decided to preserve their cash position by terminating the construction of the equipment for their Seafloor Production System. Nautilus announced on June 1, 2012 that they were in dispute with the Independent State of Papua New Guinea concerning the parties' obligations to complete the Agreement entered into in March 2011. Terminating the equipment build includes discontinuing discussions regarding an alternative vessel and associated funding solution. This means there will be a substantial delay in any starting of production operations; it may also result in an increase in the Project cost.
Nautilus Minerals, Inc. (NUSMF), closed Wednesday's trading session at $0.389, down 2.75%, on 119,311 volume with 98 trades. The average volume for the last 60 days is 93,449 and the stock's 52-week low/high is $0.329/$2.90.
Frontier Oilfield Services, Inc. (FOSI)
StockOrange reported earlier on Frontier Oilfield Services, Inc. (FOSI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Frontier Oilfield Services, Inc. specializes mainly in saltwater recovery and drilling fluid disposal. Currently, the Company, and their subsidiaries, operates approximately 100 disposal tank trucks and trailers, 30 frac rental tanks, and 13 disposal wells with estimated annualized revenue of $50 million. Frontier has growing operations centered in East Texas' Haynesville Shale. Frontier Oilfield Services' shares trade on the OTC Markets: OTCQB. The Company has their headquarters in Dallas, Texas.
Frontier Oilfield Services and their wholly owned subsidiary, Frontier Acquisition I, Inc., acquired Chico Coffman Tank Trucks, Inc. and their subsidiary Coffman Disposal, LLC, effective July 31, 2012. The Company also acquired Frontier Income and Growth, LLC (FIG) and their subsidiary Trinity Disposal & Trucking, LLC and Trinity Disposal Wells, LLC in two steps. The first step was effective May 31, 2012 and Frontier acquired 51 percent of FIG and in a second step, effective September 30, 2012, Frontier acquired the other remaining 49 percent of FIG.
Frontier Oilfield Services chose their business focus on wastewater recovery and disposal because of the recurring nature of the revenues, the relatively high margins, and the strong barriers to entry by potential competitors due to the limited supply of state permitted commercial disposal wells.
The Company's customer base includes national, integrated, and independent oil and gas exploration companies. Frontier's oilfield services include saltwater disposal and recovery, saltwater disposal well schematic, as well as oilfield roustabout services.
Frontier's East Texas operations company, Trinity Disposal and Trucking, has a client list that includes Devon Energy, GMX Resources, Wagner & Brown, Ltd., Matador Oil, NFR, Vernon Faulkner, and XTO Energy. In addition, Frontier Oilfield Services continues to have a small interest in producing wells and acreage. The Company has a minor overriding interest in two producing gas wells in Wise County, Texas and seven producing gas wells in Denton County, Texas.
Frontier Oilfield Services, Inc. (FOSI), closed Wednesday's trading session at $2.15, up 16.22%, on 100 volume with 1 trade. The average volume for the last 60 days is 2,376 and the stock's 52-week low/high is $0.50/$4.50.
3Power Energy Group, Inc. (PSPW)
Orbit Stocks reported earlier on 3Power Energy Group, Inc. (PSPW), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
3Power Energy Group, Inc.'s principle business is to sell electricity generated by solar, wind, hydro, biomass and other renewable energy resources, and to develop, build and operate power plants based on these technologies. 3Power plans to provide their clients with green power on a utility scale, from secure and reliable renewable energy sources built, owned and operated by the Group. 3Power Energy Group lists on the OTCQB. The Company has their corporate headquarters in Dubai, United Arab Emirates (U.A.E).
3Power Energy's core approach is to deliver energy in markets where there is an inherent energy gap between supply and demand or where there exists long term, stable, government backed financial support for the development of renewable energy. The Company's strategic plan is to develop power plants and sell electricity in mature and emerging global energy markets at secure rates with the highest profit margins.
In Europe, 3Power Energy expects to develop and operate power plants in Italy, France, and Turkey. In Latin America, the Company expects to operate wind farm projects in Chile and Nicaragua, with major project development also under way in other countries.
As of September 30, 2012, 3Power Energy Group has only one project, a 19.5 mega watt (MW) Chilean wind farm project, and the commercialization of this project is in its earliest stages. On August 10, 2012, 3Power Energy closed the acquisition of 75 percent of the equity of Shala Energy sh.p.k. This acquisition brought the Company 75 percent of the interest in a hydro-electrical project of a total installed power of 127.6 MW of Shala River in Albania. In connection with the acquisition of Shala Energy, 3Power Energy Group is obligated for an aggregate of 4 percent of the total project costs as facilitator fees in either cash or the Company's common stock.
The Company's customer base focus is on wholesale energy supply and private power purchase agreements, strategically directing their core capabilities on developing, constructing and operating renewable energy projects, with the objective of achieving maximum efficiency, economy and power quality for customers. 3Power's prospective clients range from Government controlled wholesale electricity markets, public power authorities and public entities, to large and medium business concerns. 3Power plans to offer a vertically integrated solution where they address every aspect of project implementation, from development and design, to financing, construction and operation.
3Power Energy Group, Inc. (PSPW), closed Wednesday's trading session at $0.061, down 6.15%, on 64,150 volume with 10 trades. The average volume for the last 60 days is 136,811 and the stock's 52-week low/high is $0.062/$0.644.
Corsa Coal Corp. (CSO.V)
We are highlighting Corsa Coal Corp.(CSO.V), here at the QualityStocks Daily Newsletter.
Listed on the TSX Venture Exchange, Corsa Coal Corp. mines, processes, and sells metallurgical coal. The Company also actively explores, acquires, and develops resource properties that are consistent with their existing coal business. Corsa Coal's wholly owned subsidiaries are Wilson Creek Energy (Somerset, Pennsylvania) and Maryland Energy Resources (Johnstown, Pennsylvania). The Company has their headquarters in Toronto, Ontario.
Corsa Coal's multi-disciplinary board and management team has a track record of success and experience in Coal Mining, Coal Marketing and Logistics, Company Building and Corporate Stewardship, Mining Valuations and Operations, Merger and Acquisition Transactions, and Capital Markets.
Corsa Coal produces and sells low volatile high quality hard metallurgical coal. The Company, through their subsidiaries, currently has three operating surface mines and one operating underground mine. Wilson Creek operates a coal preparation plant, with a nameplate capacity of 400 tons an hour. The plant is on the CSX rail line in Somerset County, Pennsylvania 170 miles from the Port of Baltimore.
The Company also has several other surface and underground properties at different stages of development. All of these properties will require various permits before mining operations could start. The mines and properties are in Cambria and Somerset Counties in Pennsylvania and Garret County, Maryland.
Last week, Corsa Coal announced an increase to their fourth quarter guidance. The Company now expects to ship (based on new sales contracts) approximately 75,000 tons in the calendar fourth quarter. Of this, they expect 55,000 tons to be taken into sales in their fiscal fourth quarter and the remainder to fall into next fiscal year sales.
Corsa Coal had previously given guidance that they expected to ship 32,000 tons of met coal in the Company's fiscal fourth quarter. Therefore, the Casselman mine, which was temporarily idled in mid-October, has restarted full operations together with their coal preparation plant. The Company continues to market their 2013 production actively and will continue to match their production to actual sales.
Corsa Coal Corp. (CSO.V), closed Wednesday's trading at $0.15, even for the day, on 58,700 volume. The stock's 52-week low/high is $0.09/$0.58.
New Mexico Software, Inc. (NMXC)
Hawk Associates reported last week on New Mexico Software, Inc. (NMXC), FeedBlitz did earlier, and we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Established in 1995, New Mexico Software, Inc., d/b/a Net Medical Xpress Solutions is a medical services company and Net Medical Xpress is a trade name of New Mexico Software. The Company provides clinical and diagnostic programs using advanced telemedicine solutions for rural hospitals. They also develop FDA 510k-cleared and all-inclusive PACS products within the preventative, comprehensive, and critical healthcare segments. New Mexico Software has their headquarters in Albuquerque, New Mexico.
New Mexico Software's Net Medical Xpress™ specializes in Web-based medical solutions. Through the Company's Net Medical Xpress Services, doctors read X-rays, CT scans, ultra-sounds, EKGs and more for their clients.
Net Medical Xpress provides XR-EXpress PACs (Picture Archiving and Communication Systems) hardware and software to hospitals and other medical facilities. They provide a FDA 510k cleared PACS available for installation at a medical facility or it can undergo integration as a "web service" while data integrity, PHI, security, and HIPAA compliance are always maintained.
The Company has three operational units: Net Medical Xpress Solutions™, the aforementioned Net Medical Xpress Services™ and Net Medical Xpress Specialists. Concerning Net Medical Xpress Services™, their 40 American Board-certified radiologists and 15 board certified cardiologists diagnose plain film, ultra sounds, CT, MRI, Echo, EKG, and Fluoroscopy's 24/7/365.
Pertaining to Net Medical Xpress Specialists, their clinical unit provides telemedicine to remote hospitals with specialists credentialed for services. These services include neurology as well as stroke services, cardiology, infectious diseases, renal exams, retinal, psychology, and dermatology.
Last week, New Mexico Software announced financial results for the third fiscal quarter ended September 30, 2012. Gross revenues rose 34 percent to $964,000 from $719,000 in the third quarter of 2011. Net loss narrowed to ($19,000) or ($0.00 per share) from a net loss of ($71,000 or $0.00 per share) a year prior. Revenue from Radiological Services rose 32 percent to $801,000 from $608,000 a year prior. Total operating costs for the quarter were up 14.5 percent to $705,000.
For the first nine months of 2012, gross revenues were $2,847,000. This represents a gain of 17.9 percent over the first nine months of 2011. Net loss for the first nine months was ($54,000) compared with a net loss of ($165,000) in the first nine months of 2011.
New Mexico Software, Inc. (NMXC), closed today at $0.035, up 9.38%, on 81,500 volume with 5 trades. The average volume for the last 60 days is 16,114 and the stock's 52-week low/high is $0.017/$0.04.
VIASPACE, Inc. (VSPC)
The QualityStocks Daily Newsletter would like to spotlight VIASPACE, Inc. (VSPC). Today, VIASPACE, Inc. closed trading at $0.0126, up 14.55%, on 85,000 volume with 5 trades. The stock’s average daily volume over the past 60 days is 1,581,958, and its 52-week low/high is $0.0013/$0.015.
VIASPACE, Inc. (VSPC) is focused on growing renewable Giant King™ Grass as a low-carbon fuel for clean electricity generation and environmentally friendly energy pellets, as well as a feedstock for bio-methane production, green cellulosic biofuels, biochemical, and biomaterials. A high-yield, low-cost feedstock, Giant King Grass meets the cost targets of green energy applications while maintaining a carbon neutral profile.
The highest yielding biomass crop in the world, Giant King Grass can grow in a variety of soil conditions and does not compete with food crops. Once Giant King Grass is established, it can be harvested at 3-5 feet tall every 45 to 60 days or at 14 feet tall twice a year. This incredibly high rate of growth provides a continual supply of biomass year-round, enabling strategically located power plants to operate 24 hours a day regardless of the current season.
VIASPACE provides Giant King™ Grass seedlings and technical expertise to qualified projects. The company also plans to serve as a project developer or co-developer for power plant or pellet mill projects, together with local partners that have land and require electricity, heat, pellets, biogas, or biofuels. VIASPACE and its partners are capable of delivering an integrated Giant King Grass plantation and biomass power plant project in just 24 months.
The excellent energy characteristics of Giant King Grass and its ability to be harvested multiple times each year enable and energy output yield that is much higher than other crops . This superior feedstock offers material productivity benefits at remarkable costs for energy production, biofuels, and biomaterials. Giant King Grass is currently being grown in the United States, Virgin Islands, China, and other areas. Disclaimer
VIASPACE, Inc. Company Blog
VIASPACE, Inc. News:
VIASPACE, Inc. Announces Engagement of QualityStocks Investor Relations Services
Renewable Giant King Grass is Growing in St. Croix; VIASPACE Now on Facebook and Twitter
VIASPACE CEO Presents at Asian Development Bank Renewable Energy Conference and Meets Customers in Myanmar
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.18, up 2.86%, on 201,738 volume with 58 trades. The stock’s average daily volume over the past 60 days is 118,626, and its 52-week low/high is $0.174/$0.69.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corp Subsidiary Lifeline Skin Care Announces Latest Product Launch
International Stem Cell Corp Announces Third Quarter 2012 Financial Results
International Stem Cell Corporation to Host Third Quarter 2012 Financial Results Conference Call at 11:00 a.m. ET on Friday, November 9, 2012
Cardium Therapeutics, Inc. (CXM)
The QualityStocks Daily Newsletter would like to spotlight Cardium Therapeutics, Inc. (CXM). Today, Cardium Therapeutics, Inc. closed trading at $0.2097, up 4.90%, on 200,660 volume with 167 trades. The stock’s average daily volume over the past 60 days is 218,434, and its 52-week low/high is $0.17/$0.42.
Cardium Therapeutics, Inc. (CXM) is a health sciences and regenerative medicine company focused on acquiring and strategically developing new and innovative products and businesses to address significant unmet medical needs. Comprised of large-market opportunities with definable pathways to commercialization, partnering, and other economic monetizations, Cardium's current portfolio includes the Tissue Repair Company, Cardium Biologics, and the company's in-house MedPodium Health Sciences healthy lifestyle product platform.
The company's lead commercial product Excellagen® topical gel for wound care management recently received FDA clearance for marketing and sale in the United States. In addition to plans to advance the product's commercialization in the U.S. and internationally via strategic partnerships, the company plans to develop new product extensions for additional wound healing applications and is working towards securing approval for marketing and sale in South Korea and through the CE Mark application process in the European Union.
Generx®, Cardium's lead clinical development product candidate, is a DNA-based angiogenic biologic designed to treat patients with myocardial ischemia due to coronary artery disease. Cardium recently initiated its Generx Phase 3 / registration study in Russia. Consistent with its capital-efficient business model, Cardium is also actively evaluating new technologies and business opportunities. The company utilizes its team's skills in late-stage product development to bridge the critical gap between promising new technologies and product opportunities that are ready for commercialization.
Cardium is dedicated to building on its core products and product candidates to continually create new opportunities for greater success. Leveraging the advantages of its capital-efficient, asset-based business strategy, the company provides a diversified and more balanced portfolio of risk/return opportunities with the chief objective of providing long-term shareholder value. Disclaimer
Cardium Therapeutics, Inc. Company Blog
Cardium Therapeutics, Inc. News:
"Cardium Announces Patent Award For Rights To Gene Therapy for Coronary Heart Disease, Resolves Long-standing IP Competition"
Cardium Presents Third Quarter 2012 Financial Results and Reports on Recent Developments
Cardium Announces Excellagen Poster Presentatons At Desert Foot 9th Annual High Risk Diabetic Foot Conference
TNI BioTech, Inc. (TNIB)
The QualityStocks Daily Newsletter would like to spotlight TNI BioTech, Inc. (TNIB). Today, TNI BioTech, Inc. closed trading at $7.99, off by 2.56%, on 27,295 volume with 62 trades. The stock’s average daily volume over the past 60 days is 49,523, and its 52-week low/high is $0.72/$10.01.
TNI BioTech, Inc. (TNIB) is focused on utilizing patented immunotherapy to activate and mobilize the body's immune system to combat fatal diseases. The company's products and technologies improve the treatment and diagnosis of cancer, infections such as HIV/AIDS, and autoimmune diseases. Future initiatives include treatment for multiple sclerosis, herpes viral infections, and other conditions that result in altered-immune response.
The company's product portfolio currently includes IRT-101, an active immunotherapy that works by activating a patient's immune system against infectious diseases and tumor cells; IRT-102, an adaptive immunotherapy that works by isolating and enriching a patient's own immune cells; and IRT-103, an active immunotherapy that works by activating a patient's immune system against HIV/AIDS and tumor cells.
Leveraging the advantages of today's cutting-edge treatment options, the company aims to meet the growing demand for quality healthcare with safer, more effective radiation therapy; new-targeted drug therapies; and minimally invasive surgical alternatives around the world. TNI BioTech most recently signed a letter of intent to open clinics in Africa that will provide advanced treatment for cancer, HIV/AIDS, and autoimmune diseases.
The company plans to continue clinical trials in China during 2012 and 2013, and anticipates starting trials in the United States by early 2013.The company is also in negotiations to acquire a number of other immunotherapy products, patents, and therapies. Led by a management team with decades of experience and solid business plan, TNI BioTech is poised to improve healthcare with active and adaptive forms of improved immunotherapies. Disclaimer
TNI BioTech, Inc. Company Blog
TNI BioTech, Inc. News:
TNI BioTech, Inc. Signs Exclusive Distributor Agreement for Federal Republic of Nigeria with G-Ex Technologies/St. Maris Pharma & GB Pharma Holdings LLC
TNI BioTech Inc., and Hubei Qianjiang Pharmaceuticals Co., Ltd., Announce Venture Partnership for the Development of New Drug for Cancer Therapies
Dr. Henry "Skip" Lenz, Pharm.D, Joins TNI BioTech, Inc., as Quality Control Officer
TNI BioTech is combating fatal diseases by using the developing science of immunotherapy. By learning how to activate and manipulate the body’s own immune system, TNI has developed their own patented immunotherapy that promises new and better options for the treatment of cancer and infections such as HIV and autoimmune diseases. TNI’s most advanced clinical programs involve immunotherapy that isolates a patient’s lymphocytes and then incubates them together with Methionine Enkephalin (MENK). The lymphocytes are then reinfused back into the patient where they combat and destroy tumor cells.
A primary target for immunotherapy is cancer, and it’s an approach that has important advantages over standard cancer treatments. Although the use of non-immunotherapy cancer drugs, together with radiation, represents a major accomplishment in the war against various cancers, it has come with a price. Such traditional therapies, in spite of many improvements over the past decade, do not have the inherent complexity of a bio-based immune system, and thus have less of a capacity for the programmed identification of cancer cells. As a result, their use still involves appreciable collateral damage to normal cells, increasing the number of painful and sometimes dangerous side effects. Increasing the dosage to kill more cancer cells risks more serious damage to normal cells.
Immunotherapy, on the other hand, offers the potential of accurately targeting only the specified cancer cells, leaving normal cells untouched. The result is highly effective destruction of cancer, with minimal concerns for extraneous damage and unwanted side effects. It’s a situation that has been compared to a war, where the bad guys are imbedded within the civilian population. With conventional weapons, the bigger the bombs the more civilian damage. With so-called smart bombs, the intended targets can be completely destroyed without hurting anything else.
Whether called a smart bomb or magic bullet, immunotherapy is considered by many to be the next important step in the fight against cancers and other diseases, and TNI BioTech is on the leading edge.
For additional information, visit www.TNIBiotech.com
Recently, when Bristol-Myers Squibb was forced to suspend testing of its pill for hepatitis C because one of the patients suffered heart failure, it was a major blow to the pharmaceutical giant. Bristol had spent more than a billion dollars in their search for a hepatitis C treatment, and they thought they had it with a nucleotide from an earlier acquired company called Inhibitex. The potential market is enormous for an effective remedy that is easier to administer than current hepatitis C treatments, with possible sales estimated to be well over a billion dollars. Bristol had paid $2.5 billion in cash for Inhibitex, and was in the process of performing safety tests for the drug when the heart failed in one of the test subjects. Adding to the problem was the fact that it was not even clear if the drug had actually caused the failure. In any event, Bristol-Myers was left with a lot less money and now no clear direction regarding the future of their very expensive drug.
The financial disaster was an example of exactly the type of costly mistake that VistaGen believes it can help pharmaceutical companies like Bristol-Myers avoid. VistaGen has spent years developing stem cell technology-based bioassay systems to help drug developers find out early on whether their drug candidates face a potential problem with heart or liver toxicity.
The company’s platform, called Human Clinical Trials in a Test Tube, is based upon a combination of proprietary and exclusively licensed stem cell technologies. These technologies enable controlled differentiation, or development, of pluripotent stem cells into mature human cells specific to the company’s predictive toxicology, drug metabolism, drug rescue, and cell therapy interests. In effect, it’s like having a human heart or liver in a test tube, allowing a close analysis of drug/tissue interaction at the earliest stages of development, and opening the possibility of drug rescue to leverage millions already spent by pharmaceutical companies to discover potential clinical benefits of new drug candidates put on the shelf due to heart or liver safety concerns. The potential savings all of this represents to the pharmaceutical industry is immense.
For additional information, visit www.VistaGen.com
Last week, Mark Luden, president and CEO of The Guitammer Company, sat down with Equities.com Executive Editor Henry Truc to discuss recent progress and milestones for Guitammer. Among topics discussed, Luden talked extensively about progress with Guitammer’s patented ButtKicker brand of low-frequency audio transducers, which the company has introduced as the next big thing in entertainment.
The line of ButtKicker products has added the fourth dimension of tactile sensation to entertainment. ButtKicker products allow users, both at home and in entertainment venues, to feel bass in a silent but powerful way. The company is now selling this technology throughout the world for use in movie theaters, home theaters, gaming systems, music, and other related applications. Applicable on any type of live broadcast, ButtKicker technology enhances the viewer experience for virtually every type of entertainment, from movies to sports.
“Imagine if, while you’re watching it, it was like you were in the racecar and you felt it,” Luden said.
“We now own the patent for being able to incorporate the actual feeling of the event, without any noise, to bring you in and make it a more immersive [experience] for you,” he added.
The Guitammer Company went public last year after receiving a comprehensive patent for the ButtKicker technology in March 2011. Financial progress has been rapid for the company since those milestones took place.
During the interview, Luden discussed the company’s recurring revenue plans and recent financial accomplishments, including substantial recent revenue growth and the installations of 4-D seating in China’s Sichuan Lumiere Cinema Co. chain of theaters. To date, 1,000 ButtKicker-enabled 4-D seats have been installed in theaters in China.
“The 4-D shaking seats in China are packed,” Luden said.
Overall this year, Guitammer has been working on acquiring capital structure, growing its core business, and getting first initial proof of concept underway on its broadcast technology.
To view the interview in its entirety, visit www.equities.com/tv-updates?s=8PLSFC87
For further information about The Guitammer Company, visit www.guitammer.com, www.thebuttkicker.com, or www.shakemycouch.com
Intertainment Media announced its partnership with Los Angeles, CA based, premier communications specialists, PUB 1917, to enhance their current and future digital production and corporate communications programs primarily for the automotive industry. Intertainment will provide production services and Intertainment”s Live & Global platform “Powered by Ortsbo” will increase the ability to reach North American multi-language teams and global participants. The current scope of the first year opportunity is estimated in excess of USD $500,000 and based on traction within the global automotive sector, could be considerably greater.
Among its key offerings as a creative service and production company, PUB 1917 produces strategic corporate communications, marketing, product education and specialized webcasts for automotive and commercial clients such as KIA, Hyundai, Lexus and Toyota. PUB 1917 clients also include Mercedes, Honda, Jaguar, Intel, Alcoa, Sony Pictures, Panasonic and DaVita. The webcasts have been used primarily for the automotive companies to introduce new models and specialized features to their dealers and staff and to enable interactive communications between their audience and in-studio specialists in design and engineering.
Sensing a growing need to broaden the audience internationally, PUB 1917 immediately saw the advantages of using Intertainment”s interactive technology to reach a broader audience. This technology, which has been used successfully in the Entertainment and Sports industry for Variety, KISS, Disney, IndyCar, Dreamworks, Fox, Yahoo!, MSN and other leading providers allows users and brands to interact in real time in over 65 languages, and provides all the production components to create an online real-time event. The Live & Global platform affords all viewers the ability to engage the experts by asking questions in their native language and having the question and reply immediately understood by all viewers. Intertainment will also provide specialized technology and web sites for pre-event registration to allow interactive communication during the event, as well as “Dashboards” that provide real time analytics during and after the broadcast.
PUB 1917 is managed by its co-founders Bruce Birch and Ramon P. Montoya who issued the following joint statement: “Intertainment will provide us with the missing link for real time interactive corporate communications. Finally, our clients can go beyond the English speaking audience and create an interactive, engaging, ONE WORLD event in 66 languages, potentially saving millions of dollars annually. In addition, we are beginning to see how Intertainment”s additional suite of services will contribute to a new and expanding portion of our business.”
“We are very excited to be working with the great people at PUB 1917 to expand our newly announced initiative for Intertainment to provide production services, including its Live & Global platform “Powered by Ortsbo”,” said David Lucatch, CEO Intertainment Media Inc. “Located in the heart of the global entertainment arena, Intertainment is making great strides in enabling entertainment, sports and online providers to create a richer, deeper experience to their constituents.”
Today's Top 3
Investor News Source
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Cardium Therapeutics, Inc. (CXM) Announces the Acquisition of To Go Brands
- Consorteum Holdings, Inc. (CSRH) Subsidiary, Tarsin, a Leader in Secure Mobile Platform Technology, Forges New Frontiers in Mobile Gaming with the Acquisition of To Go Brands
- GlobalWise Investments, Inc. (GWIV) Teams Up With MWA Intelligence to Participate in Two Imaging Channel Conferences
- GreeneStone Healthcare Corp. (GRST) Seeks Amex Listing - New Report Confirms Demand
- International Stem Cell Corp. (ISCO) Lifeline Cell Technology Products to Be Added to Fisher Scientific's Catalogs
- Loans4Less.com, Inc. (LFLS) Provides Preliminary Financial Results for the Third Quarter of 2012
- Skinny Nutritional Corp. (SKNY) to Change the Way You Think About Your Water With the Introduction of Skinny Water pH+
- TNI BioTech Inc. (TNIB) and Hubei Qianjiang Pharmaceuticals Co., Ltd., Announce Venture Partnership for the Development of New Drug for Cancer Therapies
- VistaGen Therapeutics, Inc. (VSTA) Completes $3.25 Million Financing and $3.0 Million Debt Restructuring